<code id='A94B43CAE5'></code><style id='A94B43CAE5'></style>

<acronym id='A94B43CAE5'></acronym>

<center id='A94B43CAE5'><center id='A94B43CAE5'><tfoot id='A94B43CAE5'></tfoot></center><abbr id='A94B43CAE5'><dir id='A94B43CAE5'><tfoot id='A94B43CAE5'></tfoot><noframes id='A94B43CAE5'>

<optgroup id='A94B43CAE5'><strike id='A94B43CAE5'><sup id='A94B43CAE5'></sup></strike><code id='A94B43CAE5'></code></optgroup>

<b id='A94B43CAE5'><label id='A94B43CAE5'><select id='A94B43CAE5'><dt id='A94B43CAE5'><span id='A94B43CAE5'></span></dt></select></label></b><u id='A94B43CAE5'></u>

~~<i id='A94B43CAE5'><strike id='A94B43CAE5'><tt id='A94B43CAE5'><pre id='A94B43CAE5'></pre></tt></strike></i>~~

Home» explore» explore

explore

explore

author：hotspot 2025-09-29 07:29:46 Page View：7

Alexis Borisy — Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Readout LOUD podcast: 2023 in review, and a look at biotech in 2024
Next article： State Dept. review finds Biden bears some blame for Afghanistan failures

explore

Virginia high school admissions case could be legal follow

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

The SUPPORT Act is critical to fighting the opioid crisis

The SUPPORT Act is critical to fighting the opioid crisis

AdobeFewpublichealthchallengeshavebeenmoredauntingandpersistentthantheopioidcrisis,whichstartedbecau

Medical leaders decry Supreme Court decision on affirmative action

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

10 reasons why health care startups fail

AdobeInourrolesatMedTechInnovator,aglobalacceleratorformedtechstartups,we’veworkedwiththousandsofear

read more